Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome

Clinical Endocrinology

Volumn 45, Issue 5, 1996, Pages 623-629

  Sampson, Michael ^b,c   Kong, Chiew ^b   Patel, Anita ^a   Unwin, Robert ^b   Jacobs, Howard S ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LUTEINIZING HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0029847586     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.00863.x     Document Type: Article

References (52)

1. Akazawa, K., Matsuo, O., Kosugi, T., Mihara, H. & Mori, T. (1983) The role of plasminogen activator in ovulation. Acta Physiologica Latino America, 33, 105-110.
2. Adams, J., Polson, D. & Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. British Medical Journal, 293, 355-359.
3. Beers, W.H., Strickland, S. & Reich, E. (1975) Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell, 6, 387-394.
4. Baron, A.D. (1993) Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillieres Clinical Endocrinology Metabolism, 7, 961-986.
5. Booth, N.A., Simpson, A.J., Croll, A., Bennet, B. & MacGregor, I.R. (1988) PAI-1 in plasma and platelets. British Journal of Haematoly, 70, 327-329.
6. Conway, G.S., Agrawal, R., Betteridge, D.J. & Jacobs, D.J. (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clinical Endocrinology, 37, 119-125.
7. Conway, G.S., Clark, P.M.S. & Wong, D. (1993) Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clinical Endocrinology, 38, 219-222.
8. Conway, G.S., Honour, J.W. & Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology, 30, 459-470.
9. Conway, G.S. & Jacobs, H.S. (1993) Clinical implications of hyperinsulinaemia in women. Clinical Endocrinology, 39, 623-632.
10. Dahlgren, E., Johansson, S. & Lindstedt, G. et al. (1992) Women with polycystic ovary syndrome wedge resected in 1956-1965; a long term follow up focusing on natural history and circulating hormones. Fertility and Sterility, 57, 505-513.
11. Dawson, S. & Henney, A. (1992) The status of PAI-1 as a risk factor for arterial and thrombolic disease. Atherosclerosis, 95, 105-117.
12. Dunaif, A., Segal, K.R., Futterweit, W. & Bobrjansky, A. (1989) Profound peripheral insulin resistance independent of obesity in the polycystic ovary syndrome. Diabetes, 38, 1165-1174.
13. Dunaif, A., Segal, K.R., Shelley, D.R., Green, G., Dobrjansky, A. & Licholai, T. (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41, 1257-1266.
14. Eguchi, Y., Keeton, M., Sawdey, M. & Loskutoff, D. (1991) Endotoxin induces expression of PAI-1 protein and mRNA by endothelial cells and tissues in vivo. Thrombosis and Haemostasis, 65, 652-653.
15. Eshel, A., Abdulwahid, N.A., Armar, N.A., Adams, J. & Jacobs, H.S. (1988) Pulsatile luteininising hormone releasing hormone therapy in the polycystic ovary syndrome. Fertility and Sterility, 49, 956-960.
16. Ferranini, E., Buzzigoli, G. & Bonadonna, R. et at. (1987) Insulin resistance in essential hypertension. New England Journal of Medicine, 317, 350-357.
17. Ferrari, P. & Weidmann, P. (1990) Insulin, insulin sensitivity and hypertension. Journal of Hypertension, 8, 491-500.
18. Finch, D., Davis, G., Bower, J. & Kirchner, K. (1990) Effect of insulin on renal sodium handling in hypertensive rats. Hypertension, 15, 514-518.
19. Fontbonne, A., Charles, M.A. & Thibult, N. et al. (1991) Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population - the Paris prospective study. Diabetologia, 34, 356-361.
20. Franks, S., Adams, J., Mason, H. & Poison, D. (1985) Ovulatory disorders in women with polycystic ovary syndrome. Clinics in Obstetrics and Gynaecology, 12, 605-632.
21. Graf, M.J., Richards, C.J., Brown, V., Meissner, L. & Dunaif, A. (1990) The independent effects of hyperandrogenaemia, hyperinsulinaemia and obesity on lipid and lipoprotein profiles in women. Clinical Endocrinology, 33, 119-131.
22. Hamsten, A., de Faire, U. & Walldius, G. et al. (1987) Plasminogen activator inhibitor in plasma: a risk factor for recurrent myocardial infarction. Lancet, 3.
23. Juhan-Vague, I., Vague, P., Alessi, M.C., Badier, C., Valadier, J. & Aillard, M.F. (1987) Relationship between plasma insulin, triglyceride, body mass index and plasminogen activator-1. Diabete Metabolisme, 13, 331-336.
24. Juhan-Vague, I., Roul, C., Alessi, M.C., Ardissone, J.P., Heim, M. & Vague, P. (1989) Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin. Thrombosis and Haemostasis, 61, 370-373.
25. Kooistra, T., Bosma, P.J., Tons, H.A., Van den Berg, Meyer, P. & Price, H.M. (1989) PAI-1 biosynthesis and mRNA are increased by insulin in cultured human hepatocytes. Thrombosis and Haemostasis, 62, 723.
26. Lucas, C.P., Estigarribia, J.A., Darga, L.L. & Reaven, G.M. (1985) Insulin and blood pressure in obesity. Hypertension, 7, 702-706.
27. Lissner, L., Bengtsson, C., Lapidus, L., Kristjansson, K. & Wedel, H. (1992) Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension, 20, 797-801.
28. Markiewicz et al. (1991) Relationship between fasting plasma insulin and ambulatory blood pressure in young, non-obese normotensive subjects. Journal of Hypertension, 9, 505-507.
29. Mimuro, J., Schlief, R.R. & Loskutoff, D.J. (1987) Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active plasminogen activator inhibitor-1. Blood, 70, 721-728.
30. O'Brien, E., Murphy, & Tyndall, A. et al. (1991) Twenty four hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. Journal of Hypertension, 9, 355-360.
31. Palutie, A., Salo, T., Kimmo, K.K., Peltonen, L. & Rajamiemi, H. (1987) Type I and Type IV collagenolytic activity and plasminogen activator activities in preovulatory ovarian follicles. Journal of Cell Biochemistry, 34, 108-112.
32. Perloff, D., Sokolow, M. & Cowan, R. (1983) The prognostic value of ambulatory blood pressures. Journal of the American Medical Association, 249, 2792-2798.
33. Politis, I., Srikandakumar, A. & Turner, J.D. et al. (1990) Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig. Biol. Reprod., 43, 632-642.
34. Pollare, T., Lithell, H. & Berne, C. (1990) Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism, 39, 167-174.
35. Pyorala, K. (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease. Diabetes Care, 2, 131-141.
36. Reaven, G.M. (1993) Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annual Reviews Medicine, 44, 121-131.
37. Reich, R., Miskin, R. & Tsafriri, A. (1985) Follicular plasminogen activator - involvement in ovulation. Endocrinology, 116, 516-521.
38. Ronnemaa, T., Knip, M. & Lautala, P. et al. (1991) Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Annals of Medicine, 23, 67-72.
39. Rose, H.G., Yalow, R.S., Schweitzer, P. & Schwartz, E. (1987) Insulin as a potential factor influencing blood pressure in amputees. Hypertension, 9, 421-426.
40. Rosenbaum, D., Haber, R. & Dunaif, A. (1992) GLUT 4 glucose transporter abundance correlated with decreased insulin responsiveness in adipocytes from polycystic ovary syndrome women, independent of obesity and glucose intolerance. Diabetes, 42, 62A.
41. Shen, D.C., Sheih, S.M., Chen, Y.D. & Reaven, G.M. (1988) Resistance to insulin stimulated glucose uptake in patients with hypertension. Journal of Clinical Endocrinology and Metabolism, 66, 580-583.
42. Shimuzu, H. & Bray, G.A. (1990) Effects of insulin on hypothalamic monoamine metabolism. Brain Research, 510, 251-258.
43. Shoupe, D., Kumar, D.D. & Lobao, R.A. (1983) Insulin resistance in the polycystic ovary syndrome. American Journal of Obstetrics and Gynaecology, 147, 588-592.
44. Sobey, W.J., Beer, S.F. & Carrington, C.A. et al. (1989) Sensitive and specific two-site immunoradiometric assay for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochemical Journal, 260, 535-541.
45. Stanton, A. & O'Brien, E. (1993) Noninvasive 24 hour ambulatory blood pressure monitoring: current status. Postgraduate Medical Journal, 69, 255-267.
46. Tsafriri, A., Daphna-Iken, D., Abisogun, A.O. & Reich, R. (1990) Follicular rupture during ovulation: activation of collagenolysis. In Advances in Assisted Reproductive Technologies (ed. S. Mashiach). pp. 359-363. Plenum Press, New York.
47. Tsafriri, A., Bicsak, T.A. Cajander, S.B., Ny, T. & Hsueh, A.J.W. (1989) Inhibition of ovulation by antibodies to tissue type plasminogen activator and alpha-2 antiplasmin. Endocrinology, 124, 415-421.
48. Vague, P., Juhan Vague, I., Alessi, M.C., Badier, C. & Valadier, J. (1987) Metformin decreases the high PAI capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. Thrombosis and Haemostasis, 57, 326-328.
49. Welborne, T.A. & Wearne, K. (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 2, 154-160.
50. Welin, L., Eriksson, H., Larsson, B., Ohlson, L., Svardsudd, K. & Tibblin, G. (1992) Hyperinsulinaemia is not a major coronary risk factor in elderly men. Diabetologia, 35, 766-770.
51. Yen, S.S.C. (1978) Chronic anovulation due to inappropriate feed-back system. In Reproductive Endocrinology. Eds. S.S.C. Yen & R. Jaffe, Philadelphia: Saunders. pp. 297-232.
52. Zimmermann, S., Phillips, R.A. & Dunaif, A. et al. (1992) Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. Journal of Clinical Endocrinology and Metabolism. 75, 508-513.